BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 19217528)

  • 1. 3'-Deoxy-3'-[(18)F]fluorothymidine (FLT) uptake in breast cancer cells as a measure of proliferation after doxorubicin and docetaxel treatment.
    Dittmann H; Jusufoska A; Dohmen BM; Smyczek-Gargya B; Fersis N; Pritzkow M; Kehlbach R; Vonthein R; Machulla HJ; Bares R
    Nucl Med Biol; 2009 Feb; 36(2):163-9. PubMed ID: 19217528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Hsp90 inhibitor NVP-AUY922 in multicellular tumour spheroids with respect to effects on growth and PET tracer uptake.
    Monazzam A; Razifar P; Ide S; Rugaard Jensen M; Josephsson R; Blomqvist C; Langström B; Bergström M
    Nucl Med Biol; 2009 Apr; 36(3):335-42. PubMed ID: 19324279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
    Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
    Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early detection of chemoradioresponse in esophageal carcinoma by 3'-deoxy-3'-3H-fluorothymidine using preclinical tumor models.
    Apisarnthanarax S; Alauddin MM; Mourtada F; Ariga H; Raju U; Mawlawi O; Han D; Bornmann WG; Ajani JA; Milas L; Gelovani JG; Chao KS
    Clin Cancer Res; 2006 Aug; 12(15):4590-7. PubMed ID: 16899606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of thymidine kinase 1 after 5-fluorouracil as a mechanism for 3'-deoxy-3'-[18F]fluorothymidine flare.
    Lee SJ; Kim SY; Chung JH; Oh SJ; Ryu JS; Hong YS; Kim TW; Moon DH
    Biochem Pharmacol; 2010 Nov; 80(10):1528-36. PubMed ID: 20723540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]FDG and [18F]FLT uptake in human breast cancer cells in relation to the effects of chemotherapy: an in vitro study.
    Direcks WG; Berndsen SC; Proost N; Peters GJ; Balzarini J; Spreeuwenberg MD; Lammertsma AA; Molthoff CF
    Br J Cancer; 2008 Aug; 99(3):481-7. PubMed ID: 18665170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alkyl-fluorinated thymidine derivatives for imaging cell proliferation II. Synthesis and evaluation of N3-(2-[18F]fluoroethyl)-thymidine.
    Toyohara J; Hayashi A; Gogami A; Fujibayashi Y
    Nucl Med Biol; 2006 Aug; 33(6):765-72. PubMed ID: 16934695
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Etoposide increases equilibrative nucleoside transporter 1 activity and fluorothymidine uptake: screening of 60 cytotoxic agents.
    Lee EJ; Lee SJ
    Oncol Rep; 2013 Feb; 29(2):763-70. PubMed ID: 23232555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of FLT uptake as a measure of thymidine kinase-1 activity in A549 carcinoma cells.
    Rasey JS; Grierson JR; Wiens LW; Kolb PD; Schwartz JL
    J Nucl Med; 2002 Sep; 43(9):1210-7. PubMed ID: 12215561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of docetaxel, doxorubicin and cyclophosphamide on human breast cancer cell line MCF-7.
    Trebunova M; Laputkova G; Slaba E; Lacjakova K; Verebova A
    Anticancer Res; 2012 Jul; 32(7):2849-54. PubMed ID: 22753747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Application of the multicellular tumour spheroid model to screen PET tracers for analysis of early response of chemotherapy in breast cancer.
    Monazzam A; Josephsson R; Blomqvist C; Carlsson J; Långström B; Bergström M
    Breast Cancer Res; 2007; 9(4):R45. PubMed ID: 17659092
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gef gene therapy enhances the therapeutic efficacy of doxorubicin to combat growth of MCF-7 breast cancer cells.
    Prados J; Melguizo C; Rama AR; Ortiz R; Segura A; Boulaiz H; Vélez C; Caba O; Ramos JL; Aránega A
    Cancer Chemother Pharmacol; 2010 May; 66(1):69-78. PubMed ID: 19771430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling spheroid growth, PET tracer uptake, and treatment effects of the Hsp90 inhibitor NVP-AUY922.
    Bergstrom M; Monazzam A; Razifar P; Ide S; Josephsson R; Langstrom B
    J Nucl Med; 2008 Jul; 49(7):1204-10. PubMed ID: 18552146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of apoptosis and response of extracellular matrix proteins after chemotherapy application on human breast cancer cell spheroids.
    Oktem G; Vatansever S; Ayla S; Uysal A; Aktas S; Karabulut B; Bilir A
    Oncol Rep; 2006 Feb; 15(2):335-40. PubMed ID: 16391851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [18F]-3'Deoxy-3'-fluorothymidine positron emission tomography and breast cancer response to docetaxel.
    Contractor KB; Kenny LM; Stebbing J; Rosso L; Ahmad R; Jacob J; Challapalli A; Turkheimer F; Al-Nahhas A; Sharma R; Coombes RC; Aboagye EO
    Clin Cancer Res; 2011 Dec; 17(24):7664-72. PubMed ID: 22028493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early response assessment in prostate carcinoma by ¹⁸F-fluorothymidine following anticancer therapy with docetaxel using preclinical tumour models.
    Oyama N; Hasegawa Y; Kiyono Y; Kobayashi M; Fujibayashi Y; Ponde DE; Dence C; Welch MJ; Yokoyama O
    Eur J Nucl Med Mol Imaging; 2011 Jan; 38(1):81-9. PubMed ID: 20878403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erythropoietin fails to interfere with the antiproliferative and cytotoxic effects of antitumor drugs.
    Gewirtz DA; Di X; Walker TD; Sawyer ST
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2232-8. PubMed ID: 16609039
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early response of sigma-receptor ligands and metabolic PET tracers to 3 forms of chemotherapy: an in vitro study in glioma cells.
    van Waarde A; Been LB; Ishiwata K; Dierckx RA; Elsinga PH
    J Nucl Med; 2006 Sep; 47(9):1538-45. PubMed ID: 16954564
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-Cell Characterization of 18F-FLT Uptake with Radioluminescence Microscopy.
    Sengupta D; Pratx G
    J Nucl Med; 2016 Jul; 57(7):1136-40. PubMed ID: 27081170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment.
    Graf N; Herrmann K; den Hollander J; Fend F; Schuster T; Wester HJ; Senekowitsch-Schmidtke R; zum Büschenfelde CM; Peschel C; Schwaiger M; Dechow T; Buck AK
    Mol Imaging Biol; 2008; 10(6):349-55. PubMed ID: 18704591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.